Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Acta Oncol ; 61(9): 1050-1055, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35950607

ABSTRACT

BACKGROUND: Treatment of acute promyelocytic leukaemia has emerged as a major success in hemato-oncology. While literature from the developed world boasts of outstanding outcomes, there is a paucity of data from the developing world. This study aimed to assess complications and outcomes of acute promyelocytic leukaemia in a resource-constrained setting. METHODS: We retrospectively collected data from patients diagnosed with APL from January 2016 to December 2020. RESULTS: Sixty-four patients were treated-32 in both the Sanz high and low-risk groups. In the Sanz low-risk group, 12.5% of patients received ATRA with daunorubicin and 81.25% received ATRA with ATO. In the Sanz high-risk group, 18.8% of patients received ATRA with daunorubicin, 34.3% received ATRA with daunorubicin and ATO while 40.6% received ATRA with ATO. 56.25% of patients developed differentiation syndrome. The incidence was higher in Sanz high-risk group as compared to Sanz low-risk group. 57.4% of patients had an infection at the time of presentation. 62.5% of patients developed neutropenic fever during treatment. 17.2% of patients developed pseudotumor cerebri. The 4-year EFS and OS were 71.25 and 73.13%, respectively. Sanz low-risk group had a better 4-year EFS and OS as compared to the Sanz high-risk group. Haemoglobin at presentation and Sanz high-risk group were associated with poorer outcomes with a hazard ratio of 0.8 and 3.1, respectively. Outcomes in high-risk patients were better with the use of ATRA + ATO + daunorubicin. CONCLUSION: In the Indian population, APL patients have a high incidence of differentiation syndrome, pseudotumor cerebri, and infections during induction. CR, EFS, and OS compared to the developed world can be achieved with optimal therapy. Low haemoglobin at presentation and Sanz high-risk group were associated with poorer outcomes. ATRA, ATO, and daunorubicin combination is the preferred protocol for treating high-risk patients.


Subject(s)
Antineoplastic Agents , Leukemia, Promyelocytic, Acute , Pseudotumor Cerebri , Humans , Leukemia, Promyelocytic, Acute/drug therapy , Leukemia, Promyelocytic, Acute/diagnosis , Leukemia, Promyelocytic, Acute/pathology , Tretinoin/adverse effects , Cohort Studies , Retrospective Studies , Pseudotumor Cerebri/chemically induced , Pseudotumor Cerebri/drug therapy , Antineoplastic Agents/therapeutic use , Daunorubicin/adverse effects , Syndrome , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Treatment Outcome
4.
BMJ Case Rep ; 14(3)2021 Mar 24.
Article in English | MEDLINE | ID: mdl-33762276

ABSTRACT

A 50-year-old woman presented with a right-sided isolated third cranial nerve palsy. MRI brain showed a mass lesion arising from the right clivus with extension into the cavernous sinus. Blood investigations and bone marrow biopsy were suggestive of multiple myeloma with hypercalcaemia and renal dysfunction. It was unclear at first if the intracranial lesion was due to myelomatous involvement or a separate disease entirely. The patient declined consent for a biopsy and cerebrospinal fluid analysis was inconclusive. She was treated with bortezomib based chemotherapy and the palsy resolved by day 6, which helped clinch the rare diagnosis of central nervous system (CNS) involvement by multiple myeloma. Most patients with CNS myeloma have a dismal survival of under 6 months but she is on therapy for relapse 26 months after diagnosis. While placed under the umbrella of CNS myeloma, patients with osteodural myeloma have better outcomes, perhaps due to their distinct aetiopathogenesis.


Subject(s)
Multiple Myeloma , Oculomotor Nerve Diseases , Female , Humans , Middle Aged , Multiple Myeloma/complications , Multiple Myeloma/diagnosis , Multiple Myeloma/drug therapy , Neoplasm Recurrence, Local , Oculomotor Nerve , Oculomotor Nerve Diseases/diagnosis , Oculomotor Nerve Diseases/etiology , Paralysis
5.
Indian J Hematol Blood Transfus ; 37(4): 528-533, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33250594

ABSTRACT

In COVID 19 pandemic, delivery and access of health care services have become challenging. Telemedicine services can be considered for management of patients with hematological diseases. This study included all patients who enrolled for telemedicine facility for hematology from May 15 to July 15, 2020. Patient's demographic and disease related parameters were recorded during the teleconsultation call. Overall satisfaction of attending doctor and patients were also recorded. A total of 1187 teleconsultation appointments were taken, of which 944 (79.6%) were successfully attended. Median age of patients was 38 years (range- 0.5-78 years), with 38% females. 55% of successful calls were from patients suffering a malignant hematological disorder. 24% had an active complaint pertaining to their disease or treatment. Of these, 162 (17%) were asked for a physical consultation. A significant association was found between the requirement of physical consultation and diagnosis (p < 0.001), absence of active complaint (< 0.0001) and education level of responder (p = 0.008). Patients understand that teleconsultation is helpful in preventing COVID-19 infection (71.4%) and avoids outpatient department rush (14.5%) associated with physical appointments; and around 80% patients were satisfied with the teleconsult. With the emergence of COVID 19, many localities under partial lockdown with constant fear of contacting virus amongst patients and health care providers, we can clearly see the advantages as well as feasibility of telemedicine services for our patients. The acute surge in telemedicine could be harnessed in the future to provide comprehensive and integrated care to patients of hematological disorders.

6.
BMJ Case Rep ; 20162016 Aug 24.
Article in English | MEDLINE | ID: mdl-27558190

ABSTRACT

A 33-year-old woman with no premorbidities presented to us with chest pain and worsening dyspnoea since 1 week. Systemic examination was suggestive of acute pulmonary oedema and preliminary investigations revealed evolved anterior wall myocardial infarction (MI). The patient was stabilised and taken up for angiography which revealed spontaneous coronary artery dissection (SCAD) of the left anterior descending (LAD) artery. She underwent percutaneous coronary intervention (PCI) for the same. Further investigation into the cause for the SCAD came strongly positive for systemic lupus erythematosus (SLE). She had no prior symptoms suggestive of SLE and the SCAD was its very first clinical manifestation.


Subject(s)
Coronary Vessel Anomalies/etiology , Lupus Erythematosus, Systemic/complications , Vascular Diseases/congenital , Adult , Angina Pectoris/etiology , Coronary Angiography , Coronary Vessel Anomalies/diagnostic imaging , Coronary Vessel Anomalies/surgery , Diagnosis, Differential , Dyspnea/etiology , Female , Humans , Percutaneous Coronary Intervention , Vascular Diseases/diagnostic imaging , Vascular Diseases/etiology , Vascular Diseases/surgery
7.
BMJ Case Rep ; 20152015 Dec 01.
Article in English | MEDLINE | ID: mdl-26628312

ABSTRACT

A 56-year-old woman presented with fever, pain and restriction of movement of the right temporomandibular joint. She was premorbidly diagnosed to have type 2 diabetes mellitus and rheumatoid arthritis. Local examination revealed a poorly demarcated severely tender, erythematous swelling in the right preauricular region. All haematological and biochemical investigations were within normal limits. MRI of the neck revealed the presence of a masticator space infection with intramuscular abscess involving the masseter and the temporalis muscles along with intracranial extension. Osteomyelitic changes were detected in the right mandibular condyle, temporal bone and in the temporomandibular joint. Melioidosis was suspected due to this unique clinical presentation of an abscess at an unusual and atypical site. Blood cultures identified the Gram-negative bacilli Burkholderia pseudomallei, which established the diagnosis of Melioidosis. Remarkable improvement was attained with antibiotics meropenem and cotrimoxazole, deferring the need for any surgical intervention.


Subject(s)
Melioidosis/complications , Melioidosis/diagnosis , Trismus/microbiology , Trismus/pathology , Anti-Bacterial Agents/therapeutic use , Female , Humans , Magnetic Resonance Imaging , Mandibular Condyle/microbiology , Mandibular Condyle/pathology , Masseter Muscle/microbiology , Masseter Muscle/pathology , Melioidosis/drug therapy , Meropenem , Middle Aged , Temporal Bone/microbiology , Temporal Bone/pathology , Temporomandibular Joint/microbiology , Temporomandibular Joint/pathology , Thienamycins/therapeutic use , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
8.
BMJ Case Rep ; 20122012 Nov 27.
Article in English | MEDLINE | ID: mdl-23188839

ABSTRACT

Serum concentrations of CA-125 are rarely elevated beyond 1000 U/ml in benign conditions of the ovary in postmenopausal women. In this report, the authors present an unusual case of a 78-year-old woman with an extremely elevated CA-125 concentration of 2897 U/ml without the presence of a malignancy, ascites or pleural effusion. Imaging revealed a large intra-abdominal cystic mass with irregular solid deviations on CT scan, most likely arising from an ovary. Exploratory laparotomy was performed with suspicion of ovarian cancer but histopathological analysis revealed benign serous cystic adenofibroma. This case report highlights the diagnostic challenge of extremely increased levels of CA-125 in postmenopausal women. A possible explanation for this CA-125 elevation could be the mechanical stretch of the peritoneum.


Subject(s)
CA-125 Antigen/blood , Cystadenofibroma/diagnosis , Ovarian Neoplasms/diagnosis , Peritoneum/physiopathology , Aged , Cystadenofibroma/blood , Cystadenofibroma/pathology , Cystadenofibroma/surgery , Diagnosis, Differential , Female , Humans , Ovarian Neoplasms/blood , Ovarian Neoplasms/pathology , Ovarian Neoplasms/surgery , Ovary/pathology , Stress, Physiological/physiology , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...